NCT05090111View on ClinicalTrials.gov

A Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia

PHASE1CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

June 16, 2023

Study Completion Date

June 16, 2023

Conditions
NASH - Nonalcoholic Steatohepatitis
Interventions
DRUG

ALG-055009

Single or multiple doses of ALG-055009

DRUG

Placebo

Single or multiple doses of Placebo

Trial Locations (1)

Unknown

Biotrial, Rennes

Sponsors
All Listed Sponsors
lead

Aligos Therapeutics

INDUSTRY

NCT05090111 - A Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia | Biotech Hunter | Biotech Hunter